These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 22921186

  • 1. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
    Lutz MP, Zalcberg JR, Ducreux M, Ajani JA, Allum W, Aust D, Bang YJ, Cascinu S, Hölscher A, Jankowski J, Jansen EP, Kisslich R, Lordick F, Mariette C, Moehler M, Oyama T, Roth A, Rueschoff J, Ruhstaller T, Seruca R, Stahl M, Sterzing F, van Cutsem E, van der Gaast A, van Lanschot J, Ychou M, Otto F, First St Gallen EORTC Gastrointestinal Cancer Conference 2012 Expert Panel.
    Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
    [Abstract] [Full Text] [Related]

  • 2. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
    Cohen DJ, Leichman L.
    J Clin Oncol; 2015 Jun 01; 33(16):1754-9. PubMed ID: 25918302
    [Abstract] [Full Text] [Related]

  • 3. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ, Feith M, Siewert JR.
    Ann Chir Gynaecol; 2000 Jun 01; 89(3):191-8. PubMed ID: 11079787
    [Abstract] [Full Text] [Related]

  • 4. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D.
    World J Gastroenterol; 2018 Apr 07; 24(13):1429-1439. PubMed ID: 29632424
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
    Gronnier C, Piessen G, Mariette C.
    J Visc Surg; 2012 Feb 07; 149(1):e23-33. PubMed ID: 22341763
    [Abstract] [Full Text] [Related]

  • 6. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Haverkamp L, Seesing MF, Ruurda JP, Boone J, V Hillegersberg R.
    Dis Esophagus; 2017 Jan 01; 30(1):1-7. PubMed ID: 27001442
    [Abstract] [Full Text] [Related]

  • 7. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E, Van de Velde C, Roth A, Lordick F, Köhne CH, Cascinu S, Aapro M, European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Eur J Cancer; 2008 Jan 01; 44(2):182-94. PubMed ID: 18093827
    [Abstract] [Full Text] [Related]

  • 8. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.
    Lutz MP, Zalcberg JR, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch HI, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, Röcken C, Roviello F, Schneider PM, Seewald S, Smyth E, van Cutsem E, Verheij M, Wagner AD, Otto F.
    Eur J Cancer; 2019 May 01; 112():1-8. PubMed ID: 30878666
    [Abstract] [Full Text] [Related]

  • 9. (Neo)-adjuvant chemo(-radio) therapy for adenocarcinomas of the gastroesophageal junction and the stomach in the West.
    Wilke H, Lordick F, Meyer HJ, Stahl M.
    Dig Surg; 2013 May 01; 30(2):112-8. PubMed ID: 23867587
    [Abstract] [Full Text] [Related]

  • 10. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH.
    Surg Oncol Clin N Am; 2006 Oct 01; 15(4):803-24. PubMed ID: 17030275
    [Abstract] [Full Text] [Related]

  • 11. Treatment approaches to esophagogastric junction tumors.
    Kurokawa Y, Sasako M, Doki Y.
    Dig Surg; 2013 Oct 01; 30(2):169-73. PubMed ID: 23867594
    [Abstract] [Full Text] [Related]

  • 12. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
    Mönig SP, Schröder W, Beckurts KT, Hölscher AH.
    Hepatogastroenterology; 2001 Oct 01; 48(41):1231-7. PubMed ID: 11677937
    [Abstract] [Full Text] [Related]

  • 13. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
    Zhang XH, Wang QZ.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 01; 30(12):947-9. PubMed ID: 19174001
    [No Abstract] [Full Text] [Related]

  • 14. Localized adenocarcinoma of the esophagogastric junction--is there a standard of care?
    Power DG, Reynolds JV.
    Cancer Treat Rev; 2010 Aug 01; 36(5):400-9. PubMed ID: 20117883
    [Abstract] [Full Text] [Related]

  • 15. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC, Schlechtweg N, Veltzke-Schlieker W, Thuss-Patience P, Pratschke J, Neuhaus P, Schumacher G.
    Zentralbl Chir; 2009 Sep 01; 134(5):455-61. PubMed ID: 19757346
    [Abstract] [Full Text] [Related]

  • 16. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S, Habermehl D, Agha A, Belka C, Combs SE, Eckel R, Friess H, Gerbes A, Nüssler NC, Schepp W, Schmid RM, Schmitt W, Schubert-Fritschle G, Weber B, Werner J, Engel J.
    Strahlenther Onkol; 2018 Feb 01; 194(2):125-135. PubMed ID: 29071366
    [Abstract] [Full Text] [Related]

  • 17. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K, Cade R.
    ANZ J Surg; 2009 Apr 01; 79(4):251-7. PubMed ID: 19432710
    [Abstract] [Full Text] [Related]

  • 18. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus.
    Moehler M, Baltin CT, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer HJ, Palmqvist A, Röcken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wittekind C, Wagner D, Mönig SP.
    Gastric Cancer; 2015 Jul 01; 18(3):550-63. PubMed ID: 25192931
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant (postoperative) therapy for esophageal cancer.
    Ku GY, Ilson DH.
    Thorac Surg Clin; 2013 Nov 01; 23(4):525-33. PubMed ID: 24199702
    [Abstract] [Full Text] [Related]

  • 20. [Optimal surgical approach for esophagogastric junction carcinoma].
    Yamashita H, Seto Y.
    Nihon Geka Gakkai Zasshi; 2015 Jan 01; 116(1):40-4. PubMed ID: 25842812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.